Evidence map›Paper›PMID 26217456›Full record

ReviewWorld journal of radiology2015

Perfusion computed tomography in renal cell carcinoma.

Chandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Relative Computed Tomography (CT) Enhancement Value for the Assessment of Microvascular Architecture in Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  10. Review
  11. Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma.Indian journal of urology : IJU : journal of the Urological Society of India
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chandan J DasChandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta, Department of Radiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Usha ThingujamChandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta, Department of Radiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Ananya PandaChandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta, Department of Radiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Sanjay SharmaChandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta, Department of Radiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Arun Kumar GuptaChandan J Das, Usha Thingujam, Ananya Panda, Sanjay Sharma, Arun Kumar Gupta, Department of Radiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various imaging modalities are available for the diagnosis, staging and response evaluation of patients with renal cell carcinoma (RCC). While contrast enhanced computed tomography (CT) is used as the standard of imaging for size, morphological evaluation and response assessment in RCC, a new functional imaging technique like perfusion CT (pCT), goes down to the molecular level and provides new perspectives in imaging of RCC. pCT depicts regional tumor perfusion and vascular permeability which are indirect parameters of tumor angiogenesis and thereby provides vital information regarding tumor microenvironment. Also response evaluation using pCT may predate the size criteria used in Response Evaluation Criteria in Solid Tumors, as changes in the perfusion occurs earlier following tissue kinase inhibitors before any actual change in size. This may potentially help in predicting prognosis, better selection of therapy and more accurate and better response evaluation in patients with RCC. This article describes the techniques and role of pCT in staging and response assessment in patients with RCCs.

Indexed as

AngiogenesisAnti-angiogenic therapyPerfusion computed tomographyRenal cell carcinoma

Identifiers

PMID26217456
PMCPMC4506935
OpenAlexW1031112990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.